🏅 FDA Orphan Designation

Ocuflox Ophthalmic Solution

Ofloxacin

Manufacturer: Allergan, Inc.

Indicated for:

Epithelial recurrent erosion dystrophyOrphan

FDA-Approved Indications (1)

Epithelial recurrent erosion dystrophyOrphan Designation

Treatment of bacterial corneal ulcers.

Indications & Usage

INDICATIONS AND USAGE Ofloxacin Otic Solution 0.3% is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: Otitis Externa in adults and pediatric patients, 6 months and older, due to Escherichia coli , Pseudomonas aeruginosa and Staphylococcus aureus. Chronic Suppurative Otitis Media in patients 12 years and older with perforated tympanic membranes due to Proteus mirabilis , Pseudomonas aeruginosa and Staphylococcus aureus. Acute Otitis Media in pediatric patients one year and older with tympanostomy tubes due to Haemophilus influenzae , Moraxella catarrhalis , Pseudomonas aeruginosa , Staphylococcus aureus and Streptococcus pneumoniae .

💙 Support Programs

View all →

Ocuflox Ophthalmic Solution

Allergan, Inc.

Ocuflox Ophthalmic Solution

Allergan, Inc.

Ciprofloxacin

Bayer

OFLOXACIN OTIC

Daiichi Sankyo

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.